Botulinum Toxin for Hyperhidrosis of Uncommon Areas

  • Érica O. de MonteiroEmail author
Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)


Hyperhidrosis of other facial areas is less common, but a considerable problem for affected subjects. There are few reports of BTX treatment of single parts of the face, e.g., the forehead, the nasal, and cranial region. Patients with hyperhidrosis of the face and scalp would be sufficiently treated by intradermal injections of botulinum toxin (BTX) type A.


Sweat glands Sudoriparous glands Sweat Hyperhidrosis Excessive sweating Hyperhidrosis craniofacial areas 


  1. Benson RA, Palin R, Holt PJ, Loftus IM. Diagnosis and management of hyperhidrosis. BMJ. 2013;347:f6800.CrossRefGoogle Scholar
  2. Costa, A., Talarico Filho, S., Arruda, L. H., de Sanctis Pecora, C., Ortolan, D. G., de Oliveira Monteiro, É., & Patriota, R. C. R. Estudo clínico multicêntrico, prospectivo, comparativo, randomizado e duplo cego, entre duas formulações de toxina botulínica tipo A registradas no Brasil para o tratamento das rugas da glabela. Surg & Cosmet Dermatol 2016;8(1):33–40.Google Scholar
  3. Lauchli S, Burg G. Treatment of hyperhidrosis with botulinum toxin A. Skin Ther Lett. 2003;8(7):1–4.Google Scholar
  4. Modified protocol for the application of botulinum toxin type A for hyperhidrosis of the nose. Available from: Accessed 7 Aug 2016.
  5. Monteiro ÉDO. Anestésicos tópicos:[revisão]. RBM Rev Bras Med. 2008;65(esp):12–8.Google Scholar
  6. Monteiro ÉDO. Uso avançado da toxina botulínica do tipo A na face. RBM Rev Bras Med. 2009;66Google Scholar
  7. Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G, Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity based treatment of focal hyperhidrosis. Dermatol Surg. 2007;33(8):908–23.PubMedGoogle Scholar
  8. Talarico Filho S, Bagatin E, de Oliveira Monteiro É, Pinheiro MVB, Hassun KM. Eficácia e segurança da neurotoxina botulínica tipo A* no tratamento de linhas de expressão glabelares. RBM Rev Bras Med. 2008;65:28–33.Google Scholar
  9. Wolosker N, Teivelis MP, Krutman M, Campbell TPDDA, Kauffman P, Campos JRD, Puech-Leão P. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912–6.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Dermatology and Cosmetic Dermatology Brazilian Magazine - RBMSão PauloBrazil

Personalised recommendations